Savara Inc Selling, General and Administrative Expense
Savara Inc (SVRA) reported Selling, General and Administrative Expense of $1.58 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2017-05-09
- Savara Inc selling, general and administrative expense for the quarter ending 2017-03-31 was $1.58M, a 44.09% decline year-over-year.
- Savara Inc selling, general and administrative expense for the quarter ending 2016-12-31 was $1.93M, a 23.10% decline year-over-year.
- Savara Inc selling, general and administrative expense for the quarter ending 2016-09-30 was $2.13M, a 13.25% decline year-over-year.
- Savara Inc selling, general and administrative expense for the quarter ending 2016-06-30 was $2.44M, a 1.20% increase year-over-year.
- Savara Inc selling, general and administrative expense for fiscal 2016 was $9.34M, a 14.79% decline from fiscal 2015.
- Savara Inc selling, general and administrative expense for fiscal 2015 was $10.96M, a 15.55% increase from fiscal 2014.
- Savara Inc selling, general and administrative expense for fiscal 2014 was $9.49M, a 11.39% increase from fiscal 2013.
- Savara Inc selling, general and administrative expense for fiscal 2013 was $8.52M, a 13.28% increase from fiscal 2012.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed | Selling, General and Administrative Expense 181 month | Selling, General and Administrative Expense 184 month | Selling, General and Administrative Expense 187 month | Selling, General and Administrative Expense 190 month | Selling, General and Administrative Expense 193 month | Selling, General and Administrative Expense 196 month | Selling, General and Administrative Expense 199 month | Selling, General and Administrative Expense 202 month | Selling, General and Administrative Expense 205 month | Selling, General and Administrative Expense 208 month | Selling, General and Administrative Expense 211 month | Selling, General and Administrative Expense 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $1.58M 10-Q · filed 2017-05-09 | $3.52M derived: sum of 2 quarters · filed 2017-05-09 | $5.65M derived: sum of 3 quarters · filed 2017-05-09 | $8.09M derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||||||
| 2016-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $4.07M derived: sum of 2 quarters · filed 2017-03-06 | $6.51M derived: sum of 3 quarters · filed 2017-03-06 | $9.34M 10-K · filed 2017-03-06 | ||||||||||||||||
| 2016-09-30 | $2.13M 10-Q · filed 2016-11-08 | $4.57M derived: sum of 2 quarters · filed 2016-11-08 | $7.41M 10-Q · filed 2016-11-08 | $9.92M derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||||||
| 2016-06-30 | $2.44M 10-Q · filed 2016-08-09 | $5.27M 10-Q · filed 2016-08-09 | $7.79M derived: sum of 3 quarters · filed 2017-05-09 | $10.25M derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||||||
| 2016-03-31 | $2.83M 10-Q · filed 2017-05-09 | $5.35M derived: sum of 2 quarters · filed 2017-05-09 | $7.81M derived: sum of 3 quarters · filed 2017-05-09 | $10.22M derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||||||
| 2015-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $4.97M derived: sum of 2 quarters · filed 2017-03-06 | $7.38M derived: sum of 3 quarters · filed 2017-03-06 | $10.96M 10-K · filed 2017-03-06 | ||||||||||||||||
| 2015-09-30 | $2.46M 10-Q · filed 2016-11-08 | $4.87M derived: sum of 2 quarters · filed 2016-11-08 | $8.45M 10-Q · filed 2016-11-08 | $10.85M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2015-06-30 | $2.41M 10-Q · filed 2016-08-09 | $5.99M 10-Q · filed 2016-08-09 | $8.38M derived: sum of 3 quarters · filed 2017-03-06 | $10.84M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2015-03-31 | $3.58M 10-Q · filed 2016-05-06 | $5.97M derived: sum of 2 quarters · filed 2017-03-06 | $8.43M derived: sum of 3 quarters · filed 2017-03-06 | $10.80M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2014-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $4.85M derived: sum of 2 quarters · filed 2017-03-06 | $7.22M derived: sum of 3 quarters · filed 2017-03-06 | $9.49M 10-K · filed 2017-03-06 | ||||||||||||||||
| 2014-09-30 | $2.46M 10-Q · filed 2015-11-12 | $2.45M 10-Q · filed 2014-10-31 | $4.83M derived: sum of 2 quarters · filed 2015-11-12 | $7.09M 10-Q · filed 2015-11-12 | $7.09M 10-Q · filed 2014-10-31 | $9.24M derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||||
| 2014-06-30 | $2.37M 10-Q · filed 2015-08-12 | $2.37M 10-Q · filed 2014-08-11 | $4.64M 10-Q · filed 2015-08-12 | $4.64M 10-Q · filed 2014-08-11 | $6.78M derived: sum of 3 quarters · filed 2015-08-12 | $8.94M derived: sum of 4 quarters · filed 2015-08-12 | ||||||||||||||
| 2014-03-31 | $2.27M 10-Q · filed 2015-05-11 | $2.27M 10-Q · filed 2014-05-05 | $4.41M derived: sum of 2 quarters · filed 2015-05-11 | $6.57M derived: sum of 3 quarters · filed 2015-05-11 | $8.67M derived: sum of 4 quarters · filed 2015-05-11 | $78.45M 10-Q · filed 2014-05-05 | ||||||||||||||
| 2013-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $4.31M derived: sum of 2 quarters · filed 2015-03-24 | $6.41M derived: sum of 3 quarters · filed 2015-03-24 | $8.52M 10-K · filed 2015-03-24 | $8.52M 10-K · filed 2014-03-26 | $76.18M 10-K · filed 2014-03-26 | ||||||||||||||
| 2013-09-30 | $2.16M 10-Q · filed 2014-10-31 | $4.26M derived: sum of 2 quarters · filed 2014-10-31 | $6.37M 10-Q · filed 2014-10-31 | $8.16M derived: sum of 4 quarters · filed 2014-10-31 | $74.04M 10-Q · filed 2013-11-04 | |||||||||||||||
| 2013-06-30 | $2.10M 10-Q · filed 2014-08-11 | $4.21M 10-Q · filed 2014-08-11 | $6.00M derived: sum of 3 quarters · filed 2014-08-11 | $7.82M derived: sum of 4 quarters · filed 2014-08-11 | $71.88M 10-Q · filed 2013-08-05 | |||||||||||||||
| 2013-03-31 | $2.11M 10-Q · filed 2014-05-05 | $3.90M derived: sum of 2 quarters · filed 2014-05-05 | $5.72M derived: sum of 3 quarters · filed 2014-05-05 | $7.59M derived: sum of 4 quarters · filed 2014-05-05 | $69.78M 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $3.60M derived: sum of 2 quarters · filed 2014-03-26 | $5.47M derived: sum of 3 quarters · filed 2014-03-26 | $7.52M 10-K · filed 2014-03-26 | $67.67M 10-K · filed 2013-03-19 | |||||||||||||||
| 2012-09-30 | $1.82M 10-Q · filed 2013-11-04 | $3.69M derived: sum of 2 quarters · filed 2013-11-04 | $5.73M 10-Q · filed 2013-11-04 | $7.54M derived: sum of 4 quarters · filed 2013-11-04 | $65.88M 10-Q · filed 2012-11-05 | |||||||||||||||
| 2012-06-30 | $1.87M 10-Q · filed 2013-08-05 | $3.92M 10-Q · filed 2013-08-05 | $5.73M derived: sum of 3 quarters · filed 2013-08-05 | $7.71M derived: sum of 4 quarters · filed 2013-08-05 | $64.06M 10-Q · filed 2012-08-06 | |||||||||||||||
| 2012-03-31 | $2.05M 10-Q · filed 2013-05-15 | $3.86M derived: sum of 2 quarters · filed 2013-05-15 | $5.84M derived: sum of 3 quarters · filed 2013-05-15 | $7.66M derived: sum of 4 quarters · filed 2013-05-15 | $62.19M 10-Q · filed 2012-05-07 | |||||||||||||||
| 2011-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19 | $3.79M derived: sum of 2 quarters · filed 2013-03-19 | $5.62M derived: sum of 3 quarters · filed 2013-03-19 | $7.19M 10-K · filed 2013-03-19 | $60.15M 10-K · filed 2012-03-08 | |||||||||||||||
| 2011-09-30 | $1.98M 10-Q · filed 2012-11-05 | $3.81M derived: sum of 2 quarters · filed 2012-11-05 | $5.38M 10-Q · filed 2012-11-05 | $6.95M derived: sum of 4 quarters · filed 2012-11-05 | $58.34M 10-Q · filed 2011-11-08 | |||||||||||||||
| 2011-06-30 | $1.82M 10-Q · filed 2012-08-06 | $3.40M 10-Q · filed 2012-08-06 | $4.96M derived: sum of 3 quarters · filed 2012-08-06 | $5.91M derived: sum of 4 quarters · filed 2012-08-06 | $56.36M 10-Q · filed 2011-08-08 | |||||||||||||||
| 2011-03-31 | $1.57M 10-Q · filed 2012-05-07 | $3.14M derived: sum of 2 quarters · filed 2012-05-07 | $4.09M derived: sum of 3 quarters · filed 2012-05-07 | $5.39M derived: sum of 4 quarters · filed 2012-05-07 | ||||||||||||||||
| 2010-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $2.51M derived: sum of 2 quarters · filed 2012-03-08 | $3.82M derived: sum of 3 quarters · filed 2012-03-08 | $4.99M 10-K · filed 2012-03-08 | ||||||||||||||||
| 2010-09-30 | $944.95K 10-Q · filed 2011-11-08 | $2.25M derived: sum of 2 quarters · filed 2011-11-08 | $3.42M 10-Q · filed 2011-11-08 | |||||||||||||||||
| 2010-06-30 | $1.30M 10-Q · filed 2011-08-08 | $2.48M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |